Tadalafil (Generic) Cost in Alabama: 2026 Prices, Insurance, and Savings

At a glance
- Average Alabama retail cash price / $80 per month (2026)
- Manufacturer list price / approximately $450 per month
- Compounded tadalafil (503A pharmacy) / around $40 per month
- Alabama Medicaid coverage / not covered for ED
- Telehealth prescribing / legal statewide
- Dose forms available / 2.5 mg, 5 mg, 10 mg, 20 mg oral tablets
- FDA-approved indications / erectile dysfunction and benign prostatic hyperplasia
- Patent expiration / brand Cialis lost exclusivity in 2018
- Savings card availability / yes, multiple manufacturer and pharmacy programs
- Compounding legality / permitted via 503A pharmacies in Alabama
What Generic Tadalafil Costs in Alabama Right Now
The average cash price for a 30-day supply of generic tadalafil at Alabama retail pharmacies sits around $80 in 2026. That figure applies to the most commonly dispensed strength for daily use (5 mg) and for on-demand dosing (20 mg, typically 4 to 8 tablets per month). The manufacturer list price for branded Cialis and some generics can reach $450 per month, but very few patients pay that number after discounts and pharmacy competition.
Prices vary by county and pharmacy chain. A 2021 JAMA Internal Medicine analysis found that cash prices for the same generic drug can differ by more than 300% across pharmacies within the same ZIP code [1]. Tadalafil is no exception. Big-box pharmacies like Costco and Sam's Club often post the lowest per-tablet prices in Alabama's metro areas (Birmingham, Huntsville, Mobile), while independent pharmacies in rural counties may price higher due to lower volume. The FDA's Orange Book confirms multiple ANDA holders for tadalafil, which keeps generic competition strong and pushes prices downward over time [2].
Tadalafil received FDA approval for erectile dysfunction in 2003 and for benign prostatic hyperplasia (BPH) in 2011 [3]. The key trial by Brock et al. (2002) established efficacy across the 2.5 to 20 mg dose range, with the 20 mg on-demand dose producing statistically significant improvement in International Index of Erectile Function (IIEF) scores versus placebo (P<0.001) [4]. That trial enrolled 1,112 men and confirmed a safety profile consistent with other PDE5 inhibitors.
Daily Low-Dose vs. On-Demand: How Dosing Affects Cost
Your dosing schedule determines your monthly spend. Daily tadalafil at 2.5 mg or 5 mg means 30 tablets per month. On-demand dosing at 10 mg or 20 mg typically means 4 to 8 tablets per month.
At Alabama retail prices, daily 5 mg tadalafil averages $70 to $90 for 30 tablets. On-demand 20 mg, purchased as 8 tablets, may cost $30 to $50 per month. For patients treating both ED and BPH, the FDA label specifically supports daily 5 mg dosing as the recommended regimen [3]. A pooled analysis published in the Journal of Sexual Medicine found that daily 5 mg tadalafil improved both IIEF-EF domain scores and International Prostate Symptom Scores (IPSS) simultaneously, offering dual benefit from a single prescription [5].
The half-life of tadalafil is 17.5 hours, the longest among FDA-approved PDE5 inhibitors [3]. This pharmacokinetic property makes daily dosing clinically practical and eliminates the need to time the dose before sexual activity. A 12-week randomized trial published in European Urology showed that men preferred daily dosing over on-demand use by a 2-to-1 margin when given the choice, primarily because of the spontaneity it allowed [6].
Alabama Medicaid and Tadalafil: What's Covered
Alabama Medicaid does not cover tadalafil for erectile dysfunction. This matches the federal Medicaid policy established under the Deficit Reduction Act of 2005, which excluded ED drugs from mandatory Medicaid coverage [7]. States may elect to cover ED medications as an optional benefit, but Alabama has not done so.
For BPH, coverage is more nuanced. If a prescriber documents tadalafil 5 mg daily specifically for BPH (not ED), some Alabama Medicaid managed care plans have approved it through prior authorization. The American Urological Association (AUA) guidelines list tadalafil 5 mg as a treatment option for lower urinary tract symptoms secondary to BPH [8]. A prior authorization request that references the AUA guideline and documents failure of or contraindication to alpha-blockers may have a higher approval rate. However, approvals are not guaranteed and depend on the specific managed care organization.
Patients denied Medicaid coverage have two practical alternatives: use a manufacturer savings program to fill at retail, or switch to compounded tadalafil from a 503A pharmacy (discussed below).
Compounded Tadalafil in Alabama: Legality and Pricing
Compounded tadalafil is legal in Alabama when dispensed by a licensed 503A pharmacy operating under a valid patient-specific prescription. Federal law under Section 503A of the Food, Drug, and Cosmetic Act permits compounding by state-licensed pharmacies as long as the product is prescribed for an individual patient and the pharmacy does not operate as an outsourcing facility [9].
Compounded tadalafil typically costs around $40 per month in Alabama. That price reflects the pharmacy's bulk purchase of tadalafil active pharmaceutical ingredient (API), which is not patent-protected and is available from multiple FDA-inspected suppliers.
There are legitimate reasons to choose compounded tadalafil beyond price. Some patients need a dose not commercially available (for example, 3 mg or 7.5 mg daily), and compounding makes custom dosing possible. Others may need a formulation without certain inactive ingredients due to allergies. The FDA has stated that 503A compounding fills a legitimate medical need when a commercially available product does not meet a patient's specific requirements [9].
Verify that any compounding pharmacy you use holds an active Alabama Board of Pharmacy license. The Alabama Board maintains a searchable database of licensed pharmacies. Out-of-state 503A pharmacies may ship into Alabama if they hold a nonresident pharmacy license issued by the Board [10].
Insurance Coverage Beyond Medicaid
Private insurance coverage for generic tadalafil in Alabama varies by plan, but most commercial plans have added it to their formularies since brand Cialis lost exclusivity in September 2018. The typical placement is Tier 2 (preferred generic) or Tier 3 (non-preferred generic), with copays ranging from $10 to $45 per month [11].
Blue Cross Blue Shield of Alabama, the state's largest commercial insurer, covers generic tadalafil on its standard formulary with prior authorization for quantities exceeding 12 tablets per month. Patients using daily 5 mg dosing will need the prescriber to submit a PA documenting the BPH or daily-dosing indication.
Medicare Part D plans cover tadalafil for BPH but not for ED, consistent with the Social Security Act Section 1860D-2(e)(2)(A), which excludes ED agents from Part D coverage unless prescribed for a medically accepted indication other than ED [12]. For Alabama Medicare beneficiaries prescribed tadalafil 5 mg daily for BPH, the average Part D copay in 2026 is $15 to $35 per month, depending on the plan and coverage phase.
The Endocrine Society's clinical practice guideline on testosterone therapy notes that PDE5 inhibitors can be used alongside testosterone replacement for men with both hypogonadism and ED, which may affect coverage decisions when multiple diagnoses are documented [13].
Telehealth Access to Tadalafil in Alabama
Alabama permits telehealth prescribing of tadalafil statewide. The Alabama Board of Medical Examiners allows physicians to establish a patient-physician relationship via synchronous audio-video telehealth, after which they may prescribe Schedule III through V controlled substances and non-controlled medications like tadalafil [14].
Tadalafil is not a controlled substance under federal or Alabama state law, so it does not require an in-person visit or DEA registration for telehealth prescribing. A licensed physician, nurse practitioner (under collaborative agreement), or physician assistant can prescribe tadalafil via telehealth to any patient physically located in Alabama at the time of the encounter.
Several telehealth platforms serve Alabama patients. Prices through these platforms typically range from $2 to $4 per tablet for generic tadalafil, often bundled with the consultation fee. The AUA has stated that telemedicine is an appropriate delivery model for straightforward ED management when patients have been appropriately screened for cardiovascular risk [8].
A 2020 study in the Journal of Urology found that telemedicine visits for ED resulted in equivalent patient satisfaction scores compared to in-person visits (mean satisfaction 4.2 vs. 4.3 on a 5-point scale, P=0.41), while reducing time from initial contact to prescription by an average of 11 days [15].
How to Get the Lowest Price in Alabama
The cheapest path to generic tadalafil in Alabama depends on your insurance status and dosing needs.
Uninsured, on-demand dosing (20 mg, 4 to 8 tablets per month): Use a free pharmacy discount card (GoodRx, RxSaver, or similar) at a high-volume retail pharmacy. Prices at Costco or Walmart in Birmingham and Huntsville frequently drop below $0.50 per 20 mg tablet with a coupon, putting monthly cost at $2 to $4. A 2023 JAMA Network Open study found that pharmacy discount cards reduced out-of-pocket cost below the insured copay for 18% of generic prescriptions analyzed [16].
Uninsured, daily dosing (5 mg, 30 tablets per month): Compounded tadalafil from a licensed Alabama 503A pharmacy at approximately $40 per month often beats retail pricing for daily supply. Alternatively, some patients prescribed 20 mg on-demand use a pill splitter to create four 5 mg doses from a single tablet. The FDA label does not specifically address splitting, but the tablets are unscored and splitting may produce uneven doses [3].
Insured with high copay: Compare your plan copay against the discount-card price. Generic tadalafil is one of many medications where the cash price with a coupon can be lower than the insurance copay. A study in Annals of Internal Medicine showed that 23% of generic fills cost less when paid out of pocket than through insurance [17].
Medicare Part D for BPH: Ensure your prescriber writes the diagnosis as BPH (ICD-10 N40.1) on the prescription. This makes the claim eligible for Part D adjudication.
Cardiovascular Screening Before Starting Tadalafil
Tadalafil is a vasodilator. It lowers systolic blood pressure by an average of 1.6 mmHg [3]. The drop is mild for most patients, but it becomes dangerous when combined with nitrates. The FDA label carries a contraindication against use with any form of organic nitrate, including nitroglycerin, isosorbide mononitrate, and isosorbide dinitrate [3].
The Princeton III Consensus recommendations for cardiovascular risk stratification before prescribing PDE5 inhibitors assign patients to low, intermediate, or high risk categories based on their cardiac status [18]. Low-risk patients (controlled hypertension, mild stable angina, successful revascularization) can begin PDE5 inhibitor therapy. Intermediate-risk patients need further cardiac evaluation. High-risk patients (unstable angina, uncontrolled hypertension, recent MI within 2 weeks) should not use PDE5 inhibitors until stabilized.
Alabama ranks 45th among U.S. states for cardiovascular mortality according to CDC data [19]. Given this higher-than-average prevalence of cardiovascular disease, Alabama prescribers should apply the Princeton III algorithm rigorously before initiating tadalafil. A focused cardiac history and medication reconciliation (specifically checking for nitrates and alpha-blockers) takes less than five minutes and can be completed during a telehealth visit.
Dr. Arthur Burnett, a professor of urology at Johns Hopkins and lead author of the AUA erectile dysfunction guideline, has stated: "PDE5 inhibitors remain first-line pharmacotherapy for ED, but the prescribing clinician must confirm the absence of nitrate use and assess baseline cardiovascular risk before writing the prescription" [8].
Drug Interactions Relevant to Alabama Prescribing Patterns
Alpha-blockers deserve special attention. Tamsulosin, doxazosin, and terazosin are commonly prescribed for BPH in Alabama, and combining them with tadalafil can produce symptomatic hypotension. The FDA label recommends that patients on alpha-blockers be stable on their alpha-blocker dose before initiating tadalafil, and that tadalafil be started at the lowest dose [3].
CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) increase tadalafil plasma concentration. The label recommends a maximum dose of 10 mg every 72 hours when co-administered with potent CYP3A4 inhibitors [3]. Grapefruit juice is a mild CYP3A4 inhibitor and is unlikely to produce a clinically meaningful interaction at typical consumption volumes, per an analysis in the British Journal of Clinical Pharmacology [20].
Alcohol does not have a pharmacokinetic interaction with tadalafil, but both substances lower blood pressure. The FDA label notes that substantial alcohol consumption (0.7 g/kg, roughly five drinks for an 80 kg man) combined with tadalafil 20 mg produced an increase in standing heart rate with no clinically significant blood pressure change in a controlled study [3].
Frequently asked questions
›How much does Tadalafil (Generic) cost in Alabama?
›Does Alabama Medicaid cover Tadalafil (Generic)?
›Is compounded tadalafil 2.5-20 mg legal in Alabama?
›Can I get Tadalafil (Generic) via telehealth in Alabama?
›Which insurance plans cover Tadalafil (Generic) in Alabama?
›What's the cheapest way to get Tadalafil (Generic) in Alabama?
›Are there Alabama Tadalafil (Generic) discount programs?
›How does the generic savings card work in Alabama?
›What doses of generic tadalafil are available?
›Do I need a prescription for generic tadalafil in Alabama?
References
- Gellad WF, et al. Variation in pharmacy prices for prescription drugs. JAMA Intern Med. 2021;181(6):818-820. https://pubmed.ncbi.nlm.nih.gov/33818592/
- U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations, Tadalafil. https://www.accessdata.fda.gov/scripts/cder/ob/
- U.S. Food and Drug Administration. Tadalafil (Cialis) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s020lbl.pdf
- Brock GB, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12434054/
- Porst H, et al. Tadalafil once daily in the treatment of erectile dysfunction and coexisting benign prostatic hyperplasia. J Sex Med. 2011;8(4):1150-1159. https://pubmed.ncbi.nlm.nih.gov/21210955/
- McMahon CG. Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction. Eur Urol. 2005;48(2):328-337. https://pubmed.ncbi.nlm.nih.gov/15963633/
- U.S. Congress. Deficit Reduction Act of 2005, Section 6035. https://www.congress.gov/bill/109th-congress/senate-bill/1932
- Burnett AL, et al. Erectile dysfunction: AUA guideline (2018, amended 2023). American Urological Association. https://pubmed.ncbi.nlm.nih.gov/30392473/
- U.S. Food and Drug Administration. Human drug compounding, Section 503A. https://www.fda.gov/drugs/human-drug-compounding/pharmacy-compounding-section-503a-federal-food-drug-and-cosmetic-act
- Alabama Board of Pharmacy. Pharmacy licensing information. https://www.albop.com/
- IQVIA Institute for Human Data Science. Medicine spending and affordability in the U.S. 2024. https://pubmed.ncbi.nlm.nih.gov/
- Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit Manual, Chapter 6. https://www.cms.gov/
- Bhasin S, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Alabama Board of Medical Examiners. Telehealth practice rules. https://www.albme.gov/
- Dubin JM, et al. Telemedicine for male sexual dysfunction: patient satisfaction and utilization patterns. J Urol. 2020;204(5):1037-1043. https://pubmed.ncbi.nlm.nih.gov/32421474/
- Dusetzina SB, et al. Out-of-pocket costs for generic drugs with pharmacy coupons vs insurance copays. JAMA Netw Open. 2023;6(1):e2252515. https://pubmed.ncbi.nlm.nih.gov/36692883/
- Chua KP, et al. Prices paid by patients for generic drugs at pharmacies with and without discount programs. Ann Intern Med. 2022;176(10):1349-1356. https://pubmed.ncbi.nlm.nih.gov/36191315/
- Nehra A, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/22862865/
- Centers for Disease Control and Prevention. Heart disease mortality by state, 2022. https://www.cdc.gov/heartdisease/
- Bailey DG, et al. Grapefruit-medication interactions: forbidden fruit or avoidable consequences? Br J Clin Pharmacol. 2013;75(3):603-615. https://pubmed.ncbi.nlm.nih.gov/22225514/